Triple negative breast cancer

Ressler S. Mlineritsch B Greil R memo – Magazine of European Medical Oncology. 2010, 3: 185-189.

Dose-dense therapy improves survival in aggressive non-Hodgkin’s lymphoma.

Fridrik MA, Hausmaninger H, Lang A, Drach J, Krieger O, Geissler D, Michlmayr G, Ulsperger E, Chott A, Oberaigner W, Greil R. Ann Hematol. 2010 Mar,89(3):273-82. doi: 10.1007/s00277-009-0811-x. Epub 2009 Aug 20.

PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia interferes with glucocorticoid-induced apoptosis.

Wasim M, Carlet M, Mansha M, Greil R, Ploner C, Trockenbacher A, Rainer J, Kofler R. J Steroid Biochem Mol Biol. 2010 Jun,120(4-5):218-27. doi: 10.1016/j.jsbmb.2010.04.019. Epub 2010 May 6.

Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories.

Fiegl M, Erdel M, Tinhofer I, Brychtova Y, Panovska A, Doubek M, Eigenberger K, Fonatsch C, Hopfinger G, MГјhlberger H, Zabernigg A, Falkner F, Gastl G, Mayer J, Greil R Ann Oncol. 2010 Dec,21(12):2410-9. doi: 10.1093/annonc/mdq236. Epub 2010 May 13.

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM N Engl J Med. 2010 Jun 17,362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5.

Evidence for the conversion of docetaxel into 7′-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy.

Czejka M, Greil R, Ulsperger E, Schnait H, Kienesberger K, Brumnik T, Farkouh A, Schierholz J. Int J Clin Pharmacol Ther. 2010 Jul,48(7):483-4.

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin’s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Eich HT, Diehl V, Görgen H, Pabst T, Markova J, Debus J, Ho A, Dörken B, Rank A, Grosu AL, Wiegel T, Karstens JH, Greil R, Willich N, Schmidberger H, Döhner H, Borchmann P, Müller-Hermelink HK, Müller RP, Engert A. J Clin Oncol. 2010 Sep 20,28(27):4199-206. doi: 10.1200/JCO.2010.29.8018. Epub 2010 Aug 16.

Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.

Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M, Egger G, Hassler MR, Thallinger C, Schmatz A, Turner SD, Greil R, Kenner L. Proc Natl Acad Sci U S A. 2010 Sep 14,107(37):16228-33. doi: 10.1073/pnas.1009719107. Epub 2010 Aug 30.

Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma.

Engert A, Plütschow A, Eich HT, Lohri A, Dörken B, Borchmann P, Berger B, Greil R, Willborn KC, Wilhelm M, Debus J, Eble MJ, Sökler M, Ho A, Rank A, Ganser A, Trümper L, Bokemeyer C, Kirchner H, Schubert J, Král Z, Fuchs M, et al. N Engl J Med. 2010 Aug 12,363(7):640-52. doi: 10.1056/NEJMoa1000067.

Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study.

Ludwig H, Adam Z, Hajek R, Greil R, TГіthovГЎ E, Keil F, Autzinger EM, Thaler J, Gisslinger H, Lang A, Egyed M, Womastek I, Zojer N. J Clin Oncol. 2010 Oct 20,28(30):4635-41. doi: 10.1200/JCO.2010.28.1238. Epub 2010 Sep 7.